Clinical Trial Detail

NCT ID NCT02260440
Title A Phase 2 Study of MK-3475 in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh

colorectal cancer


Azacitidine + Pembrolizumab

Age Groups: adult

No variant requirements are available.